Medical Accounts Receivable Funding During Current Economic Times

Medical Accounts Receivable (MAR) funding has become the finance choice to many providers seeking working capital for growth or survival. Although lowering interest rates exist in the lending community, access to the loans with such attractive rates has become challenging. A weak economy means a weak financial statement, which means weak credit evaluation, which leads to a rejected loan application.


MAR funding companies in these times are usually inundated with applicants for funding as such transactions do not require strong credit data on the applicant/provider. Medical practices and other equipment or services providers experiencing growth needs, along with decreasing and protracted payments from third party payors, can benefit from MAR funding.


Sustaining a modest 2%-4% discount as the fee for selling claims, a provider can grow and can also pay suppliers quickly taking advantage of cash discounts. Growth and vendor discounts can more than cover the low cost of MAR funding. A keen business mind will immediately recognize how a predictable cash flow can be of use especially in the economic environment we live in today. Consider using your laziest asset, your accounts receivable, to fund medical practice operations and growth.